Xcout Intel
Stipple Bio
Stipple Bio, Inc. is a private biotechnology company headquartered in Cambridge, Massachusetts, United States, focused on harnessing epitope-level precision in therapeutics.
Subscribe to see Stipple Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Stipple Bio at a glance
Stipple Bio is a biotechnology company headquartered in United States. It has raised at least $121.5M across the 3 funding rounds on record. Its most recent funding round, Series A, raised $100M in April 2026. Xcout tracks 11 named people at Stipple Bio, including Jeff Landau (CEO).
Stipple Bio leadership
- Jeff LandauCEO
- Dr. Aaron RingPresident
- Aaron RingExecutive Officer
- Jeffrey LandauExecutive Officer
- Aaron RingDirector
- Antoine YverDirector
5 more named people on record for Stipple Bio, with roles, board committees and tenure — see the full roster →
Stipple Bio funding rounds
At least $121.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $100M | 11 named | |
| SEC Form D filing | $9.5M | — | |
| SEC Form D filing | $12M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Stipple Bio competitors
A few of Stipple Bio's closest competitors — see the full list of competitors and alternatives →
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Kernal Biologics is an onco-selective mRNA therapeutics company located in Cambridge, Massachusetts, that creates mRNA therapies designed to instruct specific cells on how to make proteins.
Get Stipple Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Stipple Bio in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access